Status:
COMPLETED
B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Swiss National Science Foundation
Conditions:
Dyspnea
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Cost-effective management of heart failure and pulmonary disease is of paramount importance. Unfortunately, the rapid and accurate differentiation of heart failure from other causes of dyspnea in priv...
Detailed Description
Background: Most patients with dyspnea primarily consult physicians in private practice. Heart failure and pulmonary disease are "epidemic" disorders and account for the majority of cases of dyspnea. ...
Eligibility Criteria
Inclusion
- Acute dyspnoea is the main symptom
Exclusion
- Age \<18 years
- Obvious traumatic cause
- Severe renal dysfunction (serum creatinine \> 250 umol/l)
- Sepsis
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00130611
Start Date
January 1 2004
End Date
January 1 2011
Last Update
May 29 2013
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Private practices of Baden-Wuertemberg
Freiburg im Breisgau, Freiburg, Germany
2
Private Practices of Kanton Basel-Landschaft
Basel-Landschaft, Basel-Landschaft, Switzerland, 4100
3
Private Practices of Kanton Basel Stadt
Basel, Basel, Switzerland, 4000
4
Private practices of Kanton Aargau
Aarau, Canton of Aargau, Switzerland, 4300